October 19, 2022 without regard to Supreme Court Ruling involvement of Illegal COVID Vaccine Mandates and not reviewing the comments and human rights legalities, and the steamrolling CDC genocide agenda… ๐๐๐ ACIP decided that the COVID-19 vaccine should be added to VFC in a separate vote that took place Wednesday afternoon. This illegal early vote would counter any opposition comments and void scientific legal rhetoric— If you find the criminal gang mafia who approved illegal toxic Covid-19 non vaccines to be added to childhood vaccination schedules, please add to the comment section below so I can add the information to this ongoing article. Thank you. Who are the mystery people on CDC Independent 15 member panel that approved CDC votes to recommend vaccine for children ages? Looks like Supreme Court Ruling about Not legalizing COVID-19 Vaccine Mandates is being challenged by 15 independent people who voted to add COVID-19 Vaccinations to childhood Vaccination schedules! CDC to Vote on adding COVID-19 Immunization schedule for children in already deadly children’s vaccination schedule❤️๐ฉน‼️
Who are the mystery people on CDC Independent 15 member panel that approved CDC votes to recommend vaccine for children ages?
October 19, 2022 without regard to Supreme Court Ruling involvement of Illegal COVID Vaccine Mandates and not reviewing the comments and human rights legalities, and the steamrolling CDC genocide agenda…
“ACIP decided that the COVID-19 vaccine should be added to VFC in a separate vote that took place Wednesday afternoon.”
And…
Looks like Supreme Court Ruling about Not legalizing COVID-19 Vaccine Mandates is being challenged by 15 independent people who voted to add COVID-19 Vaccinations to childhood Vaccination schedules! CDC to Vote on adding COVID-19 Immunization schedule for children in already deadly children’s vaccination schedule❤️๐ฉน‼️
Special note: The numerous people listed cover about one year of services with CDC but not verified as members who voted to change the course of human history and increased genocide of children all ages subjected to massive toxic antigens like MRNA COVID-19 Vaccines.
CDC Web Archive
THIS WEB PAGE IS ARCHIVED FOR HISTORICAL PURPOSES AND IS NO LONGER BEING UPDATED. PLEASE GO TO CDC HOME OR USE THE A-Z INDEX OR SEARCH FOR MORE RECENT INFORMATION.
CDC Home
Search
A-Z Index
Skip directly to site contentSkip directly to page optionsSkip directly to A-Z link
Advisory Committee on Immunization Practices (ACIP)
Section Navigation
ACIP Members August 2021- June 2022
August 23, 2020: Content on this page kept for historical reasons.
Printer friendly version of ACIP Members list pdf icon[9 pages]
The ACIP includes 15 voting members responsible for making vaccine recommendations. The Secretary of the U.S. Department of Health and Human Services (DHHS) selects these members following an application and nomination process. Fourteen of the members have expertise in vaccinology, immunology, pediatrics, internal medicine, nursing, family medicine, virology, public health, infectious diseases, and/or preventive medicine; one member is a consumer representative who provides perspectives on the social and community aspects of vaccination.
In addition to the 15 voting members, ACIP includes 8 ex officio members who represent other federal agencies with responsibility for immunization programs in the United States, and 30 non-voting representatives of liaison organizations that bring related immunization expertise.
Members and representatives serve on the Committee voluntarily.
CHAIR
LEE, Grace M., MD, MPH
Associate Chief Medical Officer for Practice Innovation
Lucile Packard Children’s Hospital
Professor of Pediatrics, Stanford University School of Medicine
Stanford, CA
Term: 8/4/2021 – 6/30/2023
EXECUTIVE SECRETARY
COHN, Amanda, MD
Senior Advisor for Vaccines
National Center for Immunization and Respiratory Diseases
Centers for Disease Control and Prevention
Atlanta, GA
Members
AULT, Kevin A., MD, FACOG, FIDSA
Professor and Division Director
Department of Obstetrics and Gynecology
University of Kansas Medical Center
Kansas City, KS
Term: 10/26/2018 – 6/30/2022
BAHTA, Lynn, RN, MPH, CPH
Immunization Program Clinical Consultant
Infectious Disease, Epidemiology, Prevention & Control Division
Minnesota Department of Health
Saint Paul, Minnesota
Term: 7/1/2019 – 6/30/2023
BELL, Beth P., MD, MPH
Clinical Professor
Department of Global Health, School of Public Health
University of Washington
Seattle, WA
Term: 7/1/2019 – 6/30/2023
CHEN, Wilbur H., MD, MS, FACP, FIDSA
Professor of Medicine
Center for Vaccine Development and Global Health
University of Maryland School of Medicine
Baltimore, MD
Term: 12/23/2020 – 6/30/2024
DALEY, Matthew F., MD
Senior Investigator
Institute for Health Research
Kaiser Permanente Colorado
Aurora, CO
Term: 1/4/2021 – 6/30/2024
KOTTON, Camille Nelson, MD, FIDSA, FAST
Clinical Director, Transplant and Immunocompromised Host Infectious Diseases
Infectious Diseases Division, Massachusetts General Hospital
Associate Professor of Medicine, Harvard Medical School
Boston, MA
Term: 12/23/2020 – 6/30/2024
LONG, Sarah S., MD
Professor of Pediatrics
Drexel University College of Medicine
Section of Infectious Diseases
St. Christopher’s Hospital for Children
Philadelphia, Pennsylvania
Term: 12/24/2020 – 6/30/2024
MCNALLY, Veronica V., JD
President and CEO
Franny Strong Foundation
West Bloomfield, Michigan
Term: 10/31/2018 – 6/30/2022
POEHLING, Katherine A., MD, MPH
Professor of Pediatrics and Epidemiology and Prevention
Director, Pediatric Population Health
Department of Pediatrics
Wake Forest School of Medicine
Winston-Salem, NC
Term: 7/1/2019 – 6/30/2023
SรNCHEZ, Pablo J., M.D.
Professor of Pediatrics
The Ohio State University – Nationwide Children’s Hospital
Divisions of Neonatal-Perinatal Medicine and Pediatric Infectious Diseases
Director, Clinical & Translational Research (Neonatology)
Center for Perinatal Research
The Research Institute at Nationwide Children’s Hospital
Columbus, Ohio
Term: 7/1/2019 – 6/30/2023
TALBOT, Helen Keipp, MD
Associate Professor of Medicine
Vanderbilt University
Nashville, TN
Term: 10/29/2018 – 6/30/2022
Ex Officio Members
Centers for Medicare and Medicaid Services (CMS)
HANCE, Mary Beth
Senior Policy Advisor
Division of Quality, Evaluations and Health Outcomes
Children and Adults Health Programs Group
Center for Medicaid, CHIP and Survey & Certification
Centers for Medicare and Medicaid Services
Baltimore, MD
Food and Drug Administration (FDA)
FINK, Doran, MD, PhD
Deputy Director, Clinical, Division of Vaccines and Related Products Applications
Office of Vaccines Research and Review
Center for Biologics Evaluation and Research
Food and Drug Administration
Silver Spring, MD
Health Resources and Services Administration (HRSA)
RUBIN, Mary, MD
Chief Medical Officer
Division of Injury Compensation Programs
Rockville, MD
Indian Health Service (IHS)
WEISER, Thomas, MD, MPH
Medical Epidemiologist
Portland Area Indian Health Service
Portland, OR
Office of Infectious Disease and HIV/AIDS Policy (OIDP)
KIM, David, MD, MA
Director, Division of Vaccines, OIDP
Office of the Assistant Secretary for Health
Department of Health and Human Services
Washington, DC
National Institutes of Health (NIH)
BEIGEL, John, M.D.
Associate Director for Clinical Research
Division of Microbiology and Infectious Diseases
National Institute of Allergy and Infectious Diseases (NIAID)
Bethesda, MD
Liaison Representatives
American Academy of Family Physicians (AAFP)
ROCKWELL, Pamela G., D.O.
Associate Professor, Department of Family Medicine,
University of Michigan Medical School
Medical Director, Dominos Farms Family Medicine
Ann Arbor, MI
American Academy of Pediatrics (AAP)
MALDONADO, Yvonne, MD
Senior Associate Dean for Faculty Development and Diversity
Professor of Pediatrics and Health Research and Policy
Chief, Division of Pediatric Infectious Diseases
Stanford University School of Medicine
Stanford, CA
American Academy of Pediatrics (AAP) Red Book Editor
KIMBERLIN, David, MD
Professor of Pediatrics
Division of Pediatric Infectious Diseases
The University of Alabama at Birmingham School of Medicine
Birmingham, AL
American Academy of Physician Assistants (AAPA)
LรGER, Marie-Michรจle, MPH, PA-C
Senior Director, Clinical and Health Affairs
American Academy of Physician Assistants
Alexandria, VA
American College Health Association (ACHA)
CHAI, Thevy S., MD
Director of Medical Services
Campus Health Services
University of North Carolina at Chapel Hill
Chapel Hill, NC
American College Health Association (ACHA) (alternate)
MCMULLEN, Sharon, RN, MPH, FACHA
she/her/hers
Assistant Vice President of Student & Campus Life for Health and Wellbeing
Cornell Health
Ithaca, NY
American College of Nurse Midwives (ACNM)
HAYES, Carol E., CNM, MN, MPH, FACNM
Adjunct Professor
Georgia State University School of Nursing
Atlanta, GA
American College of Nurse Midwives (ACNM) (alternate)
MEHARRY, Pamela M., PHD, CNM
Midwifery Educator, Human Resources for Health
In partnership with University of Rwanda and University of Illinois, Chicago
American College of Obstetricians and Gynecologists (ACOG)
ECKERT, Linda O., MD, FACOG
Professor, Department of Obstetrics & Gynecology
Adjunct Professor, Department of Global Health
University of Washington
Seattle, WA
American College of Physicians (ACP)
GOLDMAN, Jason M. MD, FACP
Affiliate Assistant Professor of Clinical Biomedical Science, Florida Atlantic University, Boca Raton, Florida
Private Practice
Coral Springs, FL
American Geriatrics Society (AGS)
SCHMADER, Kenneth, MD
Professor of Medicine-Geriatrics
Geriatrics Division Chief
Duke University and Durham VA Medical Centers
Durham, NC
America’s Health Insurance Plans (AHIP)
GLUCKMAN, Robert A., MD, MACP
Chief Medical Officer, Providence Health Plans
Beaverton, OR
American Immunization Registry Association (AIRA)
COYLE, Rebecca, MSEd
Executive Director, AIRA
Washington, DC
American Medical Association (AMA)
FRYHOFER, Sandra Adamson, MD
Adjunct Associate Professor of Medicine
Emory University School of Medicine
Atlanta, GA
American Nurses Association (ANA)
RITTLE, Charles (Chad), DNP, MPH, RN
Assistant Professor, Nursing Faculty
Chatham University, School of Health Sciences
Pittsburgh, PA
American Osteopathic Association (AOA)
GROGG, Stanley E., DO
Associate Dean/Professor of Pediatrics
Oklahoma State University-Center for Health Sciences
Tulsa, OK
American Pharmacists Association (APhA)
FOSTER, Stephan L., PharmD
CAPT (Ret) U.S.P.H.S.
Professor, College of Pharmacy
University of Tennessee Health Sciences Center
Memphis, TN
Association of Immunization Managers (AIM)
HOWELL, Molly, MPH
Immunization Program Manager
North Dakota Department of Health
Bismarck, ND
Association for Prevention Teaching and Research (APTR)
McKINNEY, W. Paul, MD
Professor and Associate Dean
University of Louisville School of Public Health and Information Sciences
Louisville, KY
Association of State and Territorial Health Officials (ASTHO)
SHAH, Nirav D., MD, JD
Director
Maine Center for Disease Control and Prevention
Augusta, ME
Biotechnology Industry Organization (BIO)
ARTHUR, Phyllis A., MBA
Senior Director, Vaccines, Immunotherapeutics and Diagnostics Policy
Washington, DC
Council of State and Territorial Epidemiologists (CSTE)
HAHN, Christine, MD
State Epidemiologist
Office of Epidemiology, Food Protection and Immunization
Idaho Department of Health and Welfare
Boise, ID
Council of State and Territorial Epidemiologists (CSTE) (alternate)
LETT, Susan, MD, MPH
Medical Director, Immunization Program
Division of Epidemiology and Immunization
Massachusetts Department of Public Health
Boston, MA
Canadian National Advisory Committee on Immunization (NACI)
QUACH, Caroline, MD, MSc
Pediatric Infectious Disease Specialist and Medical Microbiologist
Medical Lead, Infection Prevention and Control Unit
Medical Co-director – Laboratory Medicine, Optilab
Montreal-CHUM
Montreal, Quรฉbec, Canada
Infectious Diseases Society of America (IDSA)
BAKER, Carol J., MD
Professor of Pediatrics
Molecular Virology and Microbiology
Baylor College of Medicine
Houston, TX
International Society for Travel Medicine (ISTM)
BARNETT, Elizabeth D, MD
Professor of Pediatrics
Boston University School of Medicine
Boston, MA
National Association of County and City Health Officials (NACCHO)
ZAHN, Matthew, MD
Medical Director, Epidemiology
Orange County Health Care Agency
Santa Ana, CA
National Association of County and City Health Officials (NACCHO) (alternate)
DUCHIN, Jeffrey, MD
Health Officer and Chief, Communicable Disease Epidemiology and Immunization Section
Public Health – Seattle and King County
Professor in Medicine
Division of Allergy and Infectious Diseases
University of Washington School of Medicine and School of Public Health
Seattle, WA
National Association of Pediatric Nurse Practitioners (NAPNAP)
STINCHFIELD, Patricia A., RN, MS, CPNP
Director
Infectious Disease/Immunology/Infection Control
Children’s Hospitals and Clinics of Minnesota
St. Paul, MN
National Foundation for Infectious Diseases (NFID)
SCHAFFNER, William, MD
Chairman, Department of Preventive Medicine
Vanderbilt University School of Medicine
Nashville, TN
National Foundation for Infectious Diseases (NFID) (alternate)
DALTON, Marla, PE, CAE
Executive Director & CEO
National Foundation for Infectious Diseases (NFID)
Bethesda, MD
National Medical Association (NMA)
WHITLEY-WILLIAMS, Patricia, MD
Professor and Chair
University of Medicine and Dentistry of New Jersey
Robert Wood Johnson Medical School
New Brunswick, NJ
Pediatric Infectious Diseases Society (PIDS)
O’LEARY, Sean, MD, MPH
Associate Professor of Pediatrics
Pediatric Infectious Diseases
General Academic Pediatrics
Children’s Hospital Colorado
University of Colorado School of Medicine
Pediatric Infectious Diseases Society (PIDS) (alternate)
SAWYER, Mark H, MD
Professor of Clinical Pediatrics
University of California, San Diego School of Medicine
San Diego, CA
Pharmaceutical Research and Manufacturers of America (PhRMA)
ROBERTSON, Corey, MD, MPH
Senior Director, US Medical, Sanofi Pasteur
Swiftwater, PA
Society for Adolescent Health and Medicine (SAHM)
MIDDLEMAN, Amy B., MD, MSEd, MPH
Professor of Pediatrics
Chief, Section of Adolescent Medicine
University of Oklahoma Health Sciences Center
Oklahoma City, OK
Society for Healthcare Epidemiology of America (SHEA)
DREES, Marci, MD, MS
Chief Infection Prevention Officer & Hospital Epidemiologist
ChristianaCare
Wilmington, DE
Associate Professor of Medicine
Sidney Kimmel Medical College at Thomas Jefferson University
Philadelphia, PA
ABC NEWSMay 12, 2021
CDC panel votes to recommend vaccine for children ages 12 to 15
PHOTO: Registered Medical Assistant Melissa Dalton inoculates a teenager with the Pfizer vaccine against coronavirus disease after Georgia authorized the vaccine for children over 12 years old, at Dekalb Pediatric Center in Decatur, Ga., May 11, 2021.
2:16Christopher Aluka Berry/Reuters
CDC panel votes to recommend vaccine for children
By Sasha Pezenik, Michelle Stoddart
An independent panel of advisers to the Centers for Disease Control and Prevention voted Wednesday to recommend the Pfizer vaccine for use in children ages 12 to 15.
It marks a crucial milestone in the nation's push to tamp down COVID-19, with more shots in more Americans' arms helping pave the gradual path towards recovery and a return to normalcy. The Food and Drug Administration authorized the Pfizer vaccine for this age group Monday.
President Joe Biden hailed the decision in remarks on vaccinations Tuesday afternoon.
"My hope is that the parents will take advantage of the vaccine, and get their kids vaccinated," Biden said. "Let's remember that millions of 16- and 17-year-olds have been safely vaccinated and as more and more Americans are vaccinated, COVID-19 hospitalizations and death rates continue to fall."
PHOTO: President Joe Biden delivers remarks on Covid-19 response and the vaccination program, from the South Court Auditorium of the White House, Washington, May 12, 2021. Nicholas Kamm/AFP via Getty Images
President Joe Biden delivers remarks on Covid-19 response and the vaccination program, from the South Court Auditorium of the White House, Washington, May 12, 2021.
Getting adolescents vaccinated was part of the plan he laid out last week with a goal of getting 70% of Americans vaccinated by July 4.
Biden touted the safety of the vaccines and also the increasing convenience of access to doses for those who want them.
MORE: How to prepare for the coming wave of COVID child vaccinations: OPINION
"This new population is going to find the vaccine rollout fast and efficient," Biden said Tuesday. "As of tomorrow, more than 15,000 pharmacies across this country will be ready to vaccinate this age group."
CVS and Walgreens announced they would begin offering vaccinations for 12- to 15-year olds on Thursday.
Parental or legal guardian consent is required to receive the vaccine and children must be accompanied by an adult. Both companies encouraged people to make appointments.
PHOTO: Middle school student Elise Robinson waits with her mother, Anya Robinson, for her first coronavirus vaccination on May 12, 2021, in Decatur, Ga.Ron Harris/AP
Middle school student Elise Robinson waits with her mother, Anya Robinson, for her first coronavirus vaccination on May 12, 2021, in Decatur, Ga.
CDC Director Rochelle Walensky signed off on the recommendation later Wednesday, meaning that vaccinating children as young as 12 is now the official recommendation by the nation's top public health experts.
While health experts said it's rare for children to get very sick with COVID-19, there is still a risk. Also, officials hope adolescent vaccinations will help lower the risk of transmission, as classrooms and summer camps both look towards reopening.
MORE: FDA authorizes Pfizer vaccine for 12-15-year-olds
It comes as children now make up 22% of recent COVID-19 cases in the nation, according to the American Academy of Pediatrics and the Children's Hospital Association report.
PHOTO: Registered Medical Assistant Melissa Dalton inoculates a teenager with the Pfizer vaccine against coronavirus disease after Georgia authorized the vaccine for children over 12 years old, at Dekalb Pediatric Center in Decatur, Ga., May 11, 2021.Christopher Aluka Berry/Reuters
Registered Medical Assistant Melissa Dalton inoculates a teenager with the Pfizer vaccine against coronavirus disease after Georgia authorized the vaccine for children over 12 years old, at Dekalb Pediatric Center in Decatur, Ga., May 11, 2021.
Pfizer's clinical trials have shown their vaccine safe and 100% effective in children ages 12-15, aligning with the 95% efficacy among adult clinical trial participants. Among the more than 1,000 adolescents who received the vaccine, there were no cases of COVID-19 recorded; there were 16 cases among the 978 participants who got the placebo.
On safety, clinical evidence showed no current safety concerns for these children receiving this two-dose vaccine, with side effects similar to those observed in adults -- like a sore arm at the injection site, fatigue and headache, which should stop within a few days of getting the shot.
Children who are fully vaccinated would be able to follow the updated guidance for vaccinated people from the CDC. That includes not having to wear masks outdoors unless in a crowded venue and not having to quarantine if there is a known exposure.
CDC to Vote on adding COVID-19 Immunization schedule for children in already deadly children’s vaccination schedule❤️๐ฉน‼️
In addition to submitting comments, ACIP committee members can be reached by phone.
- Dr. Sarah Long – 215-427-5201
- Dr. Grace Lee – 650-497-0618
- Lynn Bahta (RN) – 651-201-5505
- Dr. Beth Bell – 04-432-3059
- Dr. Oliver Brooks – 323-564-4331
- Dr. Wilbur Chen – 410-706-5328
- Dr. Sybil Cineas – 401-444-4741
- Dr. Helen Keipp Talbot – 615-322-2035
- Dr. Matthew Daley – 303-393-6604
- Dr. Camille Nelson Kotton – 617-726-3812
- Dr. Jamie Loehr – 607-697-0360
- Veronica V. McNally (attorney) – 517-432-6969
- Dr. Katherine A. Poehling – 336-716-9661 extension: 62540
- Dr. Pablo J. Sรกnchez – 614-722-4559
- Dr. Nirav D. Shah – 312-952-6092
- 30th June 2022: https://childrensunion.org/6-month-to-4-years-covid-vaccines/
- 14th February 2022: https://childrensunion.org/ccvac-pause-covid-roll-out/
- 19th January 2022: https://www.hartgroup.org/open-letter-to-the-mhra-regarding-child-death-data/
- 7th January 2022: https://www.hartgroup.org/gmc-reply-07-12-2021/ (reply to letter of 10-12-21)
- 10th December 2021: https://www.hartgroup.org/open-letter-to-the-gmc/ re consent
- 14th November 2021: https://www.hartgroup.org/open-letter-to-mhra-14-11-2021/ re safety
- 23rd August 2021: https://www.hartgroup.org/open-letter-to-mhra-23-08-2021/ re safety
- 6th June 2021: https://www.hartgroup.org/open-letter-to-mhra-06-06-2021/ re safety
- 17th May 2021: https://www.hartgroup.org/open-letter-to-mhra-17-05-2021/ re safety
- 17th May 2021: https://www.hartgroup.org/wp-content/uploads/2021/05/Covid19_Vaccine_in_Children_FULL_document.pdf appendix to above letter
Myocarditis severity has been downplayed:
It is therefore concerning that the UKHSA guidance contains advice such as:
- “Where appropriate the patient should be seen face to face and this assessment should include their vital signs.” We would consider a face-to-face assessment essential and feel the phrase “where appropriate” to be misplaced. ““If patients have mild symptoms, they do not require a referral to secondary care at this point.” Again, every patient with chest pain or palpitations should have an urgent ECG and blood sent for cardiac troponins. The term mild myocarditis refers to symptoms which resolve and therefore can only be considered a retrospective diagnosis.
- It is impossible to substantiate the statement that “the majority of cases appear to be mild and self-limiting”, whilst acknowledging that “no long-term follow-up data is available yet on hospitalised patients”
- We ask that you urgently update the advice to ensure that all patients with relevant symptoms are seen face to face and receive at minimum an ECG and cardiac troponins, proceeding to Echocardiogram and cardiac MRI if initial investigations support a diagnosis of myocarditis.
- We also urge you to recognise myocarditis as cardiac pathology and to not refer to this as a mild illness. This is misleading as we do not have long-term safety data to quantify the use of the word “mild”. Myocarditis has undoubtedly proved fatal for some.
- The guidance should also be corrected to advise that a diagnosis of vaccine-associated myocarditis should be an absolute contraindication to further doses.
- These changes should be notified to all GPs, vaccination centres and emergency medicine departments.
The following is a letter sent by the CCVAC to the Prime Minister of the UK:
Re: Covid-19 Vaccines for Children
Firstly, congratulations on becoming our new Prime Minister.
- 30th June 2022 – https://childrensunion.org/6-month-to-4-years-covid-vaccines/
- 14th February 2022 – https://childrensunion.org/ccvac-pause-covid-roll-out/
- 19th January 2022 – https://www.hartgroup.org/open-letter-to-the-mhra-regarding-child-death-data/
- 7th January 2022 – https://www.hartgroup.org/gmc-reply-07-12-2021/ (reply to letter of 10/12/21)
- 10th December 2021- https://www.hartgroup.org/open-letter-to-the-gmc/ re consent
- 14th November 2021- https://www.hartgroup.org/open-letter-to-mhra-14-11-2021/ re safety
- 23rd August 2021- https://www.hartgroup.org/open-letter-to-mhra-23-08-2021/ re safety
- 6th June 2021 – https://www.hartgroup.org/open-letter-to-mhra-06-06-2021/ re safety
- 17th May 2021- https://www.hartgroup.org/open-letter-to-mhra-17-05-2021/ re safety
- 17th May 2021 – https://www.hartgroup.org/wp-content/uploads/2021/05/Covid-19_Vaccine_in_Children_FULL_document.pdf appendix to above letter
